Laurel Wealth Advisors (North Carolina)’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-150	Closed	-$1K	–	658
2022 Q1	$1K	Hold	150	–	–	﹤0.01%	631
2021 Q4	$1K	Hold	150	–	–	﹤0.01%	632
2021 Q3	$2K	Hold	150	–	–	﹤0.01%	591
2021 Q2	$2K	Buy	+150	New	+$2K	﹤0.01%	668